Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.

Kim JH, Son YD, Kim HK, Lee SY, Cho SE, Kim YB, Cho ZH.

J Clin Psychopharmacol. 2011 Aug;31(4):507-11. doi: 10.1097/JCP.0b013e318222353a.

PMID:
21694619
2.

Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.

Alakurtti K, Johansson JJ, Tuokkola T, Någren K, Rinne JO.

Neuroimage. 2013 Nov 15;82:252-9. doi: 10.1016/j.neuroimage.2013.05.091. Epub 2013 May 28.

PMID:
23727314
3.

Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.

Takahata K, Ito H, Takano H, Arakawa R, Fujiwara H, Kimura Y, Kodaka F, Sasaki T, Nogami T, Suzuki M, Nagashima T, Shimada H, Kato M, Mimura M, Suhara T.

Psychopharmacology (Berl). 2012 Jul;222(1):165-72. doi: 10.1007/s00213-011-2633-5. Epub 2012 Jan 12.

PMID:
22237854
4.

Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.

Tateno A, Arakawa R, Okumura M, Fukuta H, Honjo K, Ishihara K, Nakamura H, Kumita S, Okubo Y.

J Clin Psychopharmacol. 2013 Apr;33(2):162-9. doi: 10.1097/JCP.0b013e3182825bce.

PMID:
23422369
5.

Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).

Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G.

J Clin Psychopharmacol. 2008 Dec;28(6):608-17. doi: 10.1097/JCP.0b013e31818ba2f6.

PMID:
19011428
6.

Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.

Graff-Guerrero A, Rajji TK, Mulsant BH, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Gerretsen P, Mar W, Pollock BG, Mamo DC.

JAMA Psychiatry. 2015 Sep;72(9):927-34. doi: 10.1001/jamapsychiatry.2015.0891.

PMID:
26131622
7.

Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.

Abi-Jaoude E, Segura B, Obeso I, Cho SS, Houle S, Lang AE, Rusjan P, Sandor P, Strafella AP.

Hum Brain Mapp. 2015 Jul;36(7):2592-601. doi: 10.1002/hbm.22793. Epub 2015 Mar 18.

PMID:
25788222
8.

Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.

Agid O, Mamo D, Ginovart N, Vitcu I, Wilson AA, Zipursky RB, Kapur S.

Neuropsychopharmacology. 2007 Jun;32(6):1209-15. Epub 2006 Nov 1.

9.

Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET.

Catafau AM, Suarez M, Bullich S, Llop J, Nucci G, Gunn RN, Brittain C, Laruelle M; Barcelona Clinical Imaging in Psychiatry Group.

Neuroimage. 2009 Jun;46(2):447-58. doi: 10.1016/j.neuroimage.2009.02.005. Epub 2009 Feb 20.

PMID:
19233294
10.

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.

Yokoi F, Gründer G, Biziere K, Stephane M, Dogan AS, Dannals RF, Ravert H, Suri A, Bramer S, Wong DF.

Neuropsychopharmacology. 2002 Aug;27(2):248-59.

11.

Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study.

Suzuki T, Graff-Guerrero A, Uchida H, Remington G, Caravaggio F, Borlido C, Pollock B, Mulsant B, Deluca V, Ismail Z, Mamo D.

Psychopharmacology (Berl). 2013 Jul;228(1):43-51. doi: 10.1007/s00213-013-3012-1. Epub 2013 Feb 17.

12.

Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.

Mizrahi R, Rusjan P, Agid O, Graff A, Mamo DC, Zipursky RB, Kapur S.

Am J Psychiatry. 2007 Apr;164(4):630-7.

PMID:
17403977
13.

Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia.

Iwata Y, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Plitman E, Chung JK, Mar W, Gerretsen P, Pollock BG, Mulsant BH, Rajji TK, Mamo DC, Graff-Guerrero A.

J Clin Psychiatry. 2016 Dec;77(12):e1557-e1563. doi: 10.4088/JCP.15m10538.

PMID:
28086010
14.

Effects of age on dopamine D2 receptor availability in striatal subdivisions: a high-resolution positron emission tomography study.

Kim JH, Son YD, Kim HK, Lee SY, Cho SE, Kim YB, Cho ZH.

Eur Neuropsychopharmacol. 2011 Dec;21(12):885-91. doi: 10.1016/j.euroneuro.2011.03.009. Epub 2011 Apr 20.

PMID:
21511442
15.

Association of harm avoidance with dopamine D2/3 receptor availability in striatal subdivisions: a high resolution PET study.

Kim JH, Son YD, Kim HK, Lee SY, Cho SE, Kim YB, Cho ZH.

Biol Psychol. 2011 Apr;87(1):164-7. doi: 10.1016/j.biopsycho.2011.02.011. Epub 2011 Feb 24.

PMID:
21354260
16.

Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia.

Arakawa R, Ito H, Takano A, Takahashi H, Morimoto T, Sassa T, Ohta K, Kato M, Okubo Y, Suhara T.

Psychopharmacology (Berl). 2008 Apr;197(2):229-35. Epub 2007 Dec 6.

PMID:
18058087
17.

Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.

Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G.

Int J Neuropsychopharmacol. 2010 Aug;13(7):951-60. doi: 10.1017/S1461145710000374. Epub 2010 Apr 15.

PMID:
20392299
18.

Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.

Ginovart N, Galineau L, Willeit M, Mizrahi R, Bloomfield PM, Seeman P, Houle S, Kapur S, Wilson AA.

J Neurochem. 2006 May;97(4):1089-103. Epub 2006 Apr 5.

19.

The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.

Graff-Guerrero A, Mamo D, Shammi CM, Mizrahi R, Marcon H, Barsoum P, Rusjan P, Houle S, Wilson AA, Kapur S.

Arch Gen Psychiatry. 2009 Jun;66(6):606-15. doi: 10.1001/archgenpsychiatry.2009.43.

PMID:
19487625
20.

Dopamine D(2/3) receptor availability and human cognitive impulsivity: a high-resolution positron emission tomography imaging study with [¹¹C]raclopride.

Kim JH, Son YD, Kim HK, Lee SY, Kim YB, Cho ZH.

Acta Neuropsychiatr. 2014 Feb;26(1):35-42. doi: 10.1017/neu.2013.29.

PMID:
25142098

Supplemental Content

Support Center